Bhogal M - Search Results

1

An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial.

Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, Hutnik CM, Yan DB. Nixon DR, et al. Among authors: bhogal m. Clin Ophthalmol. 2012;6:2097-103. doi: 10.2147/OPTH.S35394. Epub 2012 Dec 18. Clin Ophthalmol. 2012. PMID: 23269858 Free PMC article.

2

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial.

Crichton AC, Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Discepola MJ, Hutnik CM, Baptiste DC, Yan DB. Crichton AC, et al. Among authors: bhogal m. Clin Ophthalmol. 2014 May 23;8:1031-8. doi: 10.2147/OPTH.S46298. eCollection 2014. Clin Ophthalmol. 2014. PMID: 24920879 Free PMC article.

3

Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey.

Jog M, Chouinard S, Hobson D, Grimes D, Chen R, Bhogal M, Simonyi S. Jog M, et al. Among authors: bhogal m. Can J Neurol Sci. 2011 Sep;38(5):704-11. doi: 10.1017/s0317167100012270. Can J Neurol Sci. 2011. PMID: 21856572

4

Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.

Jog M, Wein T, Bhogal M, Dhani S, Miller R, Ismail F, Beauchamp R, Trentin G. Jog M, et al. Among authors: bhogal m. Can J Neurol Sci. 2016 Sep;43(5):687-96. doi: 10.1017/cjn.2016.262. Epub 2016 Jul 19. Can J Neurol Sci. 2016. PMID: 27430524 Clinical Trial.

5

Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study.

Wein T, Jog M, Bhogal M, Dhani S, Miller R, Ismail F, Beauchamp R, Trentin G. Wein T, et al. Among authors: bhogal m. Can J Neurol Sci. 2019 Nov;46(6):742-752. doi: 10.1017/cjn.2019.238. Can J Neurol Sci. 2019. PMID: 31256770

6

OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.

Boudreau G, Finkelstein I, Graboski C, Ong M, Christie S, Sommer K, Bhogal M, Davidovic G, Becker WJ. Boudreau G, et al. Among authors: bhogal m. Can J Neurol Sci. 2022 Jul;49(4):540-552. doi: 10.1017/cjn.2021.153. Epub 2021 Jul 5. Can J Neurol Sci. 2022. PMID: 34218836

7

Improvement in Quality of Life with OnabotulinumtoxinA for Cervical Dystonia: POSTURe.

Petitclerc M, Cloutier M, Naud P, Langlois M, Bhogal M, Davidovic G. Petitclerc M, et al. Among authors: bhogal m. Can J Neurol Sci. 2021 Sep;48(5):676-684. doi: 10.1017/cjn.2020.275. Epub 2020 Dec 21. Can J Neurol Sci. 2021. PMID: 33342445 Free PMC article.

8

OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study.

Becker WJ, Boudreau G, Finkelstein I, Graboski C, Ong M, Christie S, Sommer K, Bhogal M, Davidovic G. Becker WJ, et al. Among authors: bhogal m. Can J Neurol Sci. 2023 May;50(3):418-427. doi: 10.1017/cjn.2022.43. Epub 2022 Apr 25. Can J Neurol Sci. 2023. PMID: 35466897

9

Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled Trial.

Solish N, Rivers JK, Humphrey S, Muhn C, Somogyi C, Lei X, Bhogal M, Caulkins C. Solish N, et al. Among authors: bhogal m. Dermatol Surg. 2016 Mar;42(3):410-9. doi: 10.1097/DSS.0000000000000626. Dermatol Surg. 2016. PMID: 26863598 Clinical Trial.

10

Unpacking the Role of Multidimensional Romantic Jealousy in the Perpetration of Cyber Dating Abuse: The Mediating Role of Self-Esteem.

Bhogal MS, Galbraith N, Guy A, Rhead C, Lalli G. Bhogal MS, et al. Violence Vict. 2025 Jan 9:VV-2024-0139.R1. doi: 10.1891/VV-2024-0139. Online ahead of print. Violence Vict. 2025. PMID: 39788614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters